Jane Street’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-12,100
Closed -$13.8K – 12635
2026
Q2
$13.8K Sell
12,100
-400
-3% -$487 ﹤0.01% 11271
2026
Q1
$15.8K Buy
+12,500
New +$15.8K ﹤0.01% 11237
2025
Q1
– Sell
-193,700
Closed -$2.55M – 10349
2024
Q4
$2.55M Buy
193,700
+9,600
+5% +$131K ﹤0.01% 3701
2024
Q3
$2.06M Sell
184,100
-2,700
-1% -$33.8K ﹤0.01% 4404
2024
Q2
$2.01M Buy
186,800
+1,000
+0.5% +$12.9K ﹤0.01% 4547
2024
Q1
$2.77M Buy
185,800
+700
+0.4% +$11.5K ﹤0.01% 3614
2023
Q4
$3.35M Buy
+185,100
New +$2.81M ﹤0.01% 3539

Other funds holding PLRX

Jane Street's PLRX Position: Q3 2026 in Review

Jane Street increased its Pliant Therapeutics (PLRX) stake by 50% in Q3 2026, buying an estimated $72K and bringing the position to 194,878 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #9971.

Jane Street first reported a position in PLRX in Q2 2020 and has held it in 17 quarters since. The position peaked at $5.92M in Q1 2023. 84 funds tracked by Wall St. Rank hold PLRX as of Q3 2026.

  • Jane Street held 194,878 shares of Pliant Therapeutics worth $210K as of Q3 2026.
  • Jane Street bought 64,927 Pliant Therapeutics shares in Q3 2026, an estimated $72K.
  • Pliant Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #9971 holding.
  • Jane Street first reported a position in Pliant Therapeutics in Q2 2020 and has held it in 17 quarters since.
  • Jane Street's Pliant Therapeutics position peaked at $5.92M in Q1 2023.
  • 84 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.